Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 05, 2022 08:30 ET | Source: ABVC BioPharma, Inc.

ABVC BioPharma Announces Vitargus® Phase II Study Plan Approved by HREC in Australia

FREMONT, CA, Oct. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
April 26, 2022 08:30 ET | Source: ABVC BioPharma, Inc.

ABVC BioPharma Announces Vitargus Phase II Clinical Study Investigator Meeting

FREMONT, CA, April 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...